Tag: flavored vape

  • FDA Memo Questions Flavored-Vape Reversal: AP  

    FDA Memo Questions Flavored-Vape Reversal: AP  

    A newly released FDA memo is raising questions about the agency’s watershed authorization of fruit-flavored e-cigarettes after revealing that the products were not significantly more effective at helping smokers quit than tobacco-flavored alternatives, according to the Associated Press. The decision drew criticism from public health groups and Democratic lawmakers, who argue the authorization departs from the agency’s long-standing position that fruit and dessert flavors require a particularly high evidentiary standard because of their appeal to youth.

    The six-page document, published weeks after the FDA approved mango- and blueberry-flavored vaping products from Glas Inc., acknowledged that study data showed no statistically significant difference in smoking cessation outcomes between users of the fruit-flavored products and those using tobacco-flavored e-cigarettes. The finding contrasts with previous FDA authorizations of flavored products, including menthol e-cigarettes from Juul Labs and NJOY, which demonstrated measurable benefits over tobacco-flavored products.

    However, the AP said regulators explained that the Glas flavored vapes “did not have to demonstrate added adult benefit,” because young people were unlikely to use them. Glas requires users to unlock each e-cigarette with an age-verifying cellphone app. The memo indicates that FDA regulators instead relied heavily on the company’s age-verification technology, concluding that youth uptake was unlikely because users must unlock devices through a smartphone app.  The approval was finalized shortly before the departure of former FDA Commissioner Marty Makary and comes amid broader scrutiny of the agency’s recent approach to vaping regulation.

  • Researchers: Flavored-Vape Debate Needs to Follow Science, Not Politics

    Researchers: Flavored-Vape Debate Needs to Follow Science, Not Politics

    The resignation of FDA Commissioner Marty Makary on May 12 over reported tensions with President Donald Trump regarding the agency’s approval of two fruit-flavored nicotine vapes brought the flavored-vape battle front and center in American politics. The decision marked a shift from the FDA’s previous authorization of only tobacco and menthol flavors and reignited debate over flavored vaping products.

    Three public health researchers warned the debate over fruit-flavored nicotine vapes should be guided by evidence, not politics. Dr. Jamie Hartmann-Boyce from the University of Massachusetts Amherst, Dr. Holly Jarman from the University of Michigan School of Public Health, and Dr. Claire L. Ma from the University of Michigan, who study scientific evidencehealth policy, and regulation, respectively, acknowledged both sides of the debate, where studies show that sweet and fruity flavors can attract youth and non-smokers, but also that vaping is significantly less harmful than smoking and may help adult smokers quit. The authors urged lawmakers and regulators to follow scientific findings when shaping vape policy, as researchers continue to discover the benefits and risks of vape use.

  • NJOY Sues FDA Over Delays in Flavored E-Cigarette Approval

    NJOY Sues FDA Over Delays in Flavored E-Cigarette Approval

    NJOY LLC, a subsidiary of Altria Group, filed a lawsuit in federal court in Louisiana last week (August 21), accusing the U.S. Food and Drug Administration (FDA) of unlawfully delaying its review of applications to market flavored e-cigarettes. According to NJOY, the FDA has failed to adhere to statutory deadlines stipulated in the Family Smoking Prevention and Tobacco Control Act. The company claims such delays unfairly hinder its efforts to provide adult smokers with reduced-risk alternatives to combustible tobacco.

    According to the filing, in December 2020, the FDA denied NJOY’s application with only one deficiency listed: that the flavored products’ applications did not show they “would increase the likelihood of complete switching among adult smokers, compared to the Rich Tobacco and Menthol varieties” (products that were granted marketing authorization). In March 2021, NJOY responded, providing data showing the flavored products’ switch rates were 29-68% higher than the approved products after six months of use. The FDA has yet to respond despite repeated requests for updates, leading to last week’s lawsuit.

    Additionally, the filing states that documents received during a Freedom of Information Act request revealed that the Office of Science’s epidemiology staff concluded that NJOY adequately addressed the flavor-specific deficiency and that the products were associated with higher rates of cessation, and also that unrequested sales restrictions and reporting requirements offered by NJOY would, according to the Office of Health Communication and Education, mitigate concerns about potential youth initiation.

    The lawsuit underscores growing tensions between major industry firms and the FDA, which is facing a massive backlog of Premarket Tobacco Product Applications, particularly as sales of unauthorized flavored vaping products continue to surge. NJOY argues the delays not only burden its business, but also limit smokers’ access to potentially less harmful products.